This policy describes how Naproxen Sodium selects, writes, checks, updates, and corrects medicine content. Its purpose is to make the site’s limits visible, especially because naproxen information can affect urgent and high-risk decisions.
Scope and article intent
Each article should answer one identifiable reader question. Pages with closely related topics must use a different decision angle—triage, interaction review, label interpretation, monitoring, procedure planning, or comparison—rather than changing a few words in a shared template. Content that adds no distinct value should not be published simply to target another keyword.
Source hierarchy
- Current FDA-approved prescribing information and Medication Guides on DailyMed.
- FDA Drug Safety Communications and official regulatory notices.
- NIH/NLM resources, including MedlinePlus and LactMed.
- Poison Control for U.S. exposure triage and overdose contact information.
- Professional guidelines and peer-reviewed primary literature when official sources do not answer a focused question.
Commercial summaries, unsourced blogs, forums, and search snippets are not used as the factual foundation for medical claims. A source link supports verification; it does not imply that the source endorses this website.
Writing and safety rules
- Use plain language while retaining the uncertainty and conditions in the source.
- Do not provide a universal dose when products, formulations, ages, or prescriptions differ.
- Do not declare causation from timing alone or label an unrelated symptom as a proven adverse reaction.
- Do not tell readers to stop essential anticoagulant, antiplatelet, steroid, psychiatric, or other prescribed therapy without the treating clinician.
- State emergency thresholds for major bleeding, cardiovascular or stroke symptoms, airway reactions, severe skin reactions, and overdose.
- Do not invent clinician reviewers, institutional affiliation, testimonials, prevalence numbers, or manufacturer endorsement.
Review and updates
Pages should show when evidence was checked. High-risk topics—pregnancy, boxed warnings, dosing labels, interactions, and emergency action—should be revisited when official labeling or safety communications change. Link checks and outdated claims are part of review, not merely copyediting.
Corrections
Correction requests can be submitted through the Contact page. The review should compare the claim with the highest available source, determine whether the problem is factual, contextual, or wording-related, and update the page promptly when the correction is material. A reader’s personal treatment disagreement is not resolved by the website and belongs with the treating professional.
Independence and advertising
Advertising, if present, does not select article topics, wording, conclusions, or sources. Editorial content must remain distinguishable from advertising. No payment from a drug manufacturer is represented as evidence, and a brand mention is used only to clarify active ingredients or product identity.